Cash · 2011–2025

Acadia Pharmaceuticals cash

$178M−44.4% · FY2025

Acadia Pharmaceuticals (ACAD) reported $178M in cash for fiscal 2025, −44.4% year on year.

$6.9M2011$57.9M2012$11.7M2013$61.9M2014$102M2015$164M2016$69.4M2017$135M2018$190M2019$326M2020$147M2021$115M2022$189M2023$320M2024$178M2025
Acadia Pharmaceuticals — Cash, 2011–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$178M−44.4%Open →
FY20242024-12-31$320M+69.4%Open →
FY20232023-12-31$189M+64.3%Open →
FY20222022-12-31$115M−22.1%Open →
FY20212021-12-31$147M−54.8%Open →
FY20202020-12-31$326M+71.9%Open →
FY20192019-12-31$190M+40.8%Open →
FY20182018-12-31$135M+94.1%Open →
FY20172017-12-31$69.4M−57.6%Open →
FY20162016-12-31$164M+60.2%Open →
FY20152015-12-31$102M+65.1%Open →
FY20142014-12-31$61.9M+428.4%Open →
FY20132013-12-31$11.7M−79.8%Open →
FY20122012-12-31$57.9M+740.5%Open →
FY20112011-12-31$6.9M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +26.1%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Acadia Pharmaceuticals cash |url=https://companiesranked.com/en/company/acadia-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Acadia Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/acadia-pharmaceuticals/cash-on-hand

BibTeX

@misc{companiesranked-en-company-acadia-pharmaceuticals-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Acadia Pharmaceuticals cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/acadia-pharmaceuticals/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-333243 · August 5, 2026

{{cite web |title=Acadia Pharmaceuticals cash — 10-Q (0001193125-26-333243) |url=https://www.sec.gov/Archives/edgar/data/1070494/000119312526333243/acad-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Acadia Pharmaceuticals overview